Better Global ETF: Vanguard's VT vs. the iShares URTH

Vanguard Total World Stock ETF (VT) is presented as the stronger global-equity option versus iShares MSCI World ETF (URTH), with a 0.06% expense ratio versus 0.24%, a 1.8% dividend yield versus 1.4%, and $101.7 billion of AUM versus $8.2 billion. VT returned 17.4% over one year, modestly ahead of URTH's 16.3%, and holds 9,773 securities versus 1,253, including emerging-market AI supply-chain exposure such as TSMC and SK Hynix. URTH delivered slightly better five-year growth of $1,719 per $1,000 invested versus VT's $1,672, while both funds experienced similar maximum drawdowns near 26%.

Analysis

This is not a standalone alpha catalyst; it is primarily a portfolio-construction decision. The economic advantage of VT's lower fee is a near-certain 18bp annual carry benefit, roughly 90bp over five years before compounding, but only matters for holders whose switching costs and embedded gains do not exceed that benefit. The historical return gap is too small to establish a persistent performance edge because the products represent different regional and size-factor exposures rather than manager skill.

VT versus URTH is effectively a long emerging-markets/small-cap exposure and modest short U.S. mega-cap concentration trade. URTH's larger weights in NVDA, AAPL, and MSFT make it the cleaner vehicle if AI-led U.S. multiple expansion continues; VT should outperform if semiconductor manufacturing economics accrue downstream to TSM and Asian memory suppliers, or if dollar weakness and EM capital inflows broaden global equity leadership. The key second-order risk is that EM index exposure imports China-sensitive cyclicality, FX volatility, and geopolitical risk without providing a sufficiently large active AI allocation to offset a sharp U.S. tech correction.

Over the next 1-3 months, there is no identifiable fund-specific catalyst and flows are unlikely to affect highly liquid underlying equities. Over 6-18 months, relative returns hinge on whether global earnings breadth improves: easing dollar conditions, accelerating non-U.S. PMIs, and sustained AI capex would favor VT, while higher U.S. real yields or a renewed AI winner-take-most market would favor URTH. A durable break lower in the MSCI EM/MSCI World relative ratio, or renewed deterioration in Taiwan-risk pricing, would falsify the case for adding VT's incremental EM exposure.

Key Decisions for Investors

• For strategic global-beta allocations, prefer VT over URTH on a 3-5 year horizon where implementation costs are below the 18bp annual fee differential; this is a cost-efficiency decision, not a tactical AI trade.
• For a tactical 6-12 month broadening thesis, express it as long VT / short URTH in equal dollar terms, sized small: the spread is primarily long EM and global small caps versus developed-market mega-cap concentration. Target 5-8% relative upside if dollar weakness and EM earnings revisions emerge; exit if EM/World relative performance breaks to new 12-month lows.
• Retain or add URTH instead of VT if the mandate seeks maximum developed-market AI-beta exposure; its greater NVDA, AAPL, and MSFT concentration should outperform in a continued narrow U.S. technology rally.
• Do not treat exposure to TSM and Korean memory as a sufficient reason alone to rotate into VT. Monitor Taiwan geopolitical risk premia, USD strength, and semiconductor order revisions; adverse moves in any of these can overwhelm VT's fee advantage over a 1-3 month horizon.